Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation
- 1 November 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (suppl_1), S485-S497
- https://doi.org/10.1093/infdis/jit838
Abstract
Background. The Global Polio Eradication Initiative plans to stop all oral poliovirus vaccine (OPV) after wild poliovirus eradication, starting with serotype 2. Stakeholders continue to discuss the role of using inactivated poliovirus vaccine (IPV) to manage the risks of circulating vaccine-derived polioviruses (cVDPVs) during the end game. Methods. We use a poliovirus transmission and OPV evolution model to explore the impact of various routine immunization policies involving IPV on population immunity dynamics and the probability and magnitude of cVDPV emergences following OPV cessation. Results. Adding a single IPV dose to an OPV-only routine immunization schedule at or just before OPV cessation produces very limited impact on the probability of cVDPV emergences and the number of expected polio cases in settings in which we expect cVDPVs in the absence of IPV use. The highest-cost option of switching to a 3-dose IPV schedule only marginally decreases cVDPV risks. Discontinuing supplemental immunization activities while introducing IPV prior to OPV cessation leads to an increase in cVDPV risks. Conclusions. Introducing a dose of IPV in countries currently using OPV only for routine immunization offers protection from paralysis to successfully vaccinated recipients, but it does little to protect high-risk populations from cVDPV risks.Keywords
This publication has 30 references indexed in Scilit:
- Priming after a Fractional Dose of Inactivated Poliovirus VaccineNew England Journal of Medicine, 2013
- Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus ChallengePLoS Pathogens, 2012
- The Risks, Costs, and Benefits of Possible Future Global Policies for Managing PoliovirusesAmerican Journal of Public Health, 2008
- Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After EradicationRisk Analysis, 2006
- A Dynamic Model of Poliomyelitis Outbreaks: Learning from the Past to Help Inform the FutureAmerican Journal of Epidemiology, 2005
- Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived PoliovirusScience, 2002
- Outbreaks of Paralytic Poliomyelitis, 1976-1995The Journal of Infectious Diseases, 1997
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991
- Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio VaccinesThe Journal of Infectious Diseases, 1991
- Elimination of Poliomyelitis in FinlandClinical Infectious Diseases, 1984